Page 2 - Maha Katabi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Maha katabi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Maha Katabi Today - Breaking & Trending Today

Vera Therapeutics (NASDAQ:VERA) Issues Quarterly Earnings Results

Vera Therapeutics (NASDAQ:VERA) Issues Quarterly Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Josephr Young , Raymond James , Maha Katabi , Vera Therapeutics Company Profile , Vera Therapeutics Inc , Vera Therapeutics , Get Free Report , Therapeutics Stock Down , Director Maha Katabi , Vera Therapeutics Daily ,

Vera Therapeutics (NASDAQ:VERA) Sees Large Volume Increase

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) saw strong trading volume on Thursday . 980,711 shares traded hands during trading, a decline of 21% from the previous session’s volume of 1,245,474 shares.The stock last traded at $43.49 and had previously closed at $41.62. Analysts Set New Price Targets A number of equities analysts have […] ....

Raymond James , Maha Katabi , Royal Bank , Vera Therapeutics Company Profile , Vera Therapeutics Inc , Securities Exchange Commission , Ameritas Investment Partners Inc , Tower Research Capital , Vera Therapeutics , Get Free Report , Director Maha Katabi , Exchange Commission , Research Capital , Investment Partners , Amalgamated Bank , Vera Therapeutics Daily , Nasdaq Vera ,

Vera Therapeutics (NASDAQ:VERA) Earns Buy Rating from Guggenheim

Guggenheim reaffirmed their buy rating on shares of Vera Therapeutics (NASDAQ:VERA – Free Report) in a research report released on Friday, Benzinga reports. They currently have a $56.00 price target on the stock. Several other brokerages have also commented on VERA. Raymond James raised Vera Therapeutics from an outperform rating to a strong-buy rating and […] ....

Raymond James , Maha Katabi , Cantor Fitzgerald , Barclays Plc , Vanguard Group Inc , Capital Partners , Goldman Sachs Group Inc , Vera Therapeutics Inc , Vera Therapeutics , Free Report , Director Maha Katabi , Sachs Group , Get Free Report , Vera Therapeutics Daily , Nasdaq Vera , Reiterated Rating ,

Vera Therapeutics (NASDAQ:VERA) Shares Gap Down on Insider Selling

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report)’s share price gapped down before the market opened on Monday after an insider sold shares in the company. The stock had previously closed at $37.52, but opened at $36.63. Vera Therapeutics shares last traded at $37.81, with a volume of 45,552 shares traded. Specifically, Director Maha Katabi […] ....

Maha Katabi , Raymond James , Royal Bank , Vera Therapeutics Inc , Tower Research Capital , Ameritas Investment Partners Inc , Cantor Fitzgerald , Vera Therapeutics Company Profile , Vera Therapeutics , Get Free Report , Director Maha Katabi , Research Capital , Investment Partners , Amalgamated Bank , Vera Therapeutics Daily , Nasdaq Vera ,

Guggenheim Reiterates Buy Rating for Vera Therapeutics (NASDAQ:VERA)

Guggenheim Reiterates Buy Rating for Vera Therapeutics (NASDAQ:VERA)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Maha Katabi , Raymond James , Cantor Fitzgerald , Securities Exchange Commission , Ameritas Investment Partners Inc , Tower Research Capital , Royal Bank , Vera Therapeutics Inc , Vera Therapeutics , Get Free Report , Director Maha Katabi , Exchange Commission , Research Capital , Investment Partners , Amalgamated Bank , Vera Therapeutics Daily ,